Our investments

MyoPowers

MyoPowers is specialised in the development of artificial muscles to treat severe incontinence. MyoPowers has great potential to solve a major medical problem that affects the well-being of millions of patients. Its flagship product, ARTUS™, is an artificial urinary sphincter intended to treat patients with severe stress urinary incontinence.

Dr Philippe Pouletty is a Board member.

www.myopowers.com

First FinTech Closing
On the 15th of November 2017, Truffle has successfully completed the first closing of its institutional fund Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.